Leiomyoma: all 496 studies

Page 2 of 5. Open to participants first (79), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of FibroidsCompletedNCT02844920Results posted
• An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine FibroidsTerminatedNCT02811159Phase 2Results posted
• Power Morcellation Systems for Laparoscopic Hysterectomy and MyomectomyCompletedNCT02777203Not applicableResults posted
• Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)CompletedNCT02691494Phase 3Results posted
• A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine FibroidsCompletedNCT02655237Phase 3Results posted
• A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine FibroidsCompletedNCT02655224Phase 3Results posted
• Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT02654054Phase 3Results posted
• Symphion® System In-Office StudyCompletedNCT02520414Not applicableResults posted
• Pilot of Letrozole for Uterine MyomasCompletedNCT02470741Phase 4Results posted
• Safety and Effectiveness of OCL 503 in the Treatment of Women With LeiomyomataCompletedNCT02410018Not applicableResults posted
• Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine FibroidsCompletedNCT02323646Phase 2Results posted
• A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine FibroidsCompletedNCT02301897Phase 2Results posted
• Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid EmbolizationCompletedNCT02270255Phase 2Results posted
• Sonography Guided Transcervical Ablation of Uterine FibroidsCompletedNCT02228174Not applicableResults posted
• Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE ProcedureCompletedNCT02227316Phase 4Results posted
• Misoprostol for Reduction of Blood Loss During Fibroid SurgeryTerminatedNCT02209545Phase 4Results posted
• Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?CompletedNCT02192606Not applicableResults posted
• A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With LeiomyomasCompletedNCT02147197Phase 3Results posted
• A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With LeiomyomasCompletedNCT02147158Phase 3Results posted
• Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, JapCompletedNCT02131662Phase 2Results posted
• Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine FibroidsCompletedNCT01946178Not applicableResults posted
• Post Market Evaluation of Acessa With TAGTerminatedNCT01842789Not applicableResults posted
• Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)CompletedNCT01817530Phase 2Results posted
• Embozene Microspheres for Uterine Fibroid Embolization (UFE)TerminatedNCT01675011Not applicableResults posted
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01629563Phase 3Results posted
• Preemptive Analgesia Following Uterine Artery EmbolizationTerminatedNCT01555073Phase 4Results posted
• Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine FibroidsCompletedNCT01451424Phase 2Results posted
• Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine FibroidsCompletedNCT01441635Phase 2Results posted
• Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic SurgeryCompletedNCT01388907Phase 4Results posted
• MyoSure Hysteroscopic Tissue Removal System Registry StudyCompletedNCT01369758Not applicableResults posted
• ExAblate UF V2 System for the Treatment of Symptomatic Uterine FibroidsCompletedNCT01285960Not applicableResults posted
• HOME Study: Hysteroscopic Office Myomectomy EvaluationCompletedNCT01152112Not applicableResults posted
• Safety Study of ExAblate for the Treatment of Uterine FibroidsCompletedNCT01142791Not applicableResults posted
• Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine FibroidsTerminatedNCT01069120Phase 3Results posted
• Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum ToxinCompletedNCT00971620Phase 2Results posted
• An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 ExtTerminatedNCT00958893Phase 2Results posted
• Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003CompletedNCT00958334Phase 2Results posted
• Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine FibroidsCompletedNCT00897897Not applicableResults posted
• Post Market Study for an Adhesion Barrier Following Laparoscopic MyomectomyCompletedNCT00891657Not applicableResults posted
• Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine FibroidsCompletedNCT00874029Not applicableResults posted
• Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine FibroidsTerminatedNCT00853567Phase 3Results posted
• Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine FibroidsCompletedNCT00837161Phase 1/2Results posted
• Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine FibroidsTerminatedNCT00785356Phase 3Results posted
• PGL4001 Versus Placebo in Uterine MyomasCompletedNCT00755755Phase 3Results posted
• PGL4001 Versus GnRH-agonist in Uterine MyomasCompletedNCT00740831Phase 3Results posted
• Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine FibroidsTerminatedNCT00737282Phase 3Results posted
• Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine FibroidsTerminatedNCT00735553Phase 3Results posted
• Hysteroscopic Cryomyolysis for the Treatment of Submucosal LeiomyomataCompletedNCT00731341Not applicableResults posted
• ExAblate Treatment of Uterine Fibroids for Fertility EnhancementTerminatedNCT00730886Not applicableResults posted
• Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine FibroidsTerminatedNCT00702702Phase 3Results posted
• Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine FibroidsTerminatedNCT00683917Phase 2Results posted
• A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)CompletedNCT00628901Phase 4Results posted
• Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related BleedingTerminatedNCT00496080Not applicableResults posted
• MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced SonicationCompletedNCT00365989Phase 3Results posted
• Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914CompletedNCT00290251Phase 2Results posted
• Trial of Mifepristone for FibroidsCompletedNCT00133705Phase 3Results posted
• Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine FibroidsCompletedNCT00131365Not applicableResults posted
• Microwave Ablation of Uterine FibroidsActive, not recruitingNCT07780019
• Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of Clinical Studies Balancing Scar - Free and Anti - DisseminationActive, not recruitingNCT07486622
• Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire ProcedureActive, not recruitingNCT07474688
• Ultrasound-Guided Stellate Ganglion Block Plus Propofol for Perimenopausal Insomnia With AnxietyCompletedNCT07384468Not applicable
• Risk of Hysterectomy at Time of MyomectomyCompletedNCT07365969
• Bilateral Uterine Artery Occlusion During Laparoscopic MyomectomyCompletedNCT07352761Not applicable
• Investigation of the Impact of Myomectomy on Uterine Artery Doppler Velocimetry FindingsCompletedNCT07343765
• Impact of Uterine Leiomyoma Location on Uterine Artery Doppler VelocimetryCompletedNCT07186257
• Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)Active, not recruitingNCT07120945Not applicable
• Comparative Effects of Kegel Versus Clamshell Exercises on Low Back Pain in Women With Uterine Fibroids: A Randomized Clinical TrialCompletedNCT07094633Not applicable
• Use of Nitrous Oxide During Office HysteroscopyActive, not recruitingNCT07074795Not applicable
• Videos to Aid Decision Making for Fibroid TreatmentCompletedNCT07072364Not applicable
• Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal HysterectomiesCompletedNCT07046949Not applicable
• Fibroids and the Risk of Miscarriage: a Prospective Observational Study in an Early Pregnancy PopulationCompletedNCT06986616
• A Trial of SHR7280 in Healthy SubjectsCompletedNCT06969664Phase 1
• Effects of Oligo-fucoidan on Leiomyoma PatientsCompletedNCT06959966Early Phase 1
• A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy SubjectsCompletedNCT06949124Phase 1
• Sonographic Evaluation Of Uterine Fibroids At Different Locations In Patient With Irregular Menstrul CycleActive, not recruitingNCT06768879
• Preoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic MyomectomyCompletedNCT06768086
• Risk Factors and Disorders Linked to Uterine Adenomyosis on MRI in Reproductive-Age WomenCompletedNCT06697444
• Virtual Reality's Role in See&Treat HysteroscopyCompletedNCT06524934Not applicable
• Pregnancy Outcomes Following MyomectomyCompletedNCT06474065
• Ascertaining Longterm Outcomes of Fibroid TreatmentsActive, not recruitingNCT06430320
• Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine FibroidsActive, not recruitingNCT06244251Not applicable
• Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine LeiomyomaCompletedNCT06115408Phase 2/3
• Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in MyomectomyActive, not recruitingNCT06114758
• Pain Reduction and Ovarian Perfusion Following Uterine Fibroid EmbolizationTerminatedNCT06106633Not applicable
• The Sequestration of Holistic Stress Management Techniques for AdultsWithdrawnNCT06098755Not applicable
• A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)WithdrawnNCT06058728
• Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood LossCompletedNCT05986266Phase 1
• Prospective Analysis to Detect Myometrial Cells in Peritoneal Washing in Patients Undergoing Minimally Invasive Hysterectomy Using Containment Bag at University of Texas Medical BranchCompletedNCT05955651
• A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and TabletsCompletedNCT05868057Phase 1
• The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility StudyCompletedNCT05811286Not applicable
• Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal MyomectomyCompletedNCT05761418Phase 3
• Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant ManagementStatus unknownNCT05741671
• MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination TherapyActive, not recruitingNCT05739136
• Role of US in Uterine Fibroids in Comparison With MRI Using FIGO ClassificationStatus unknownNCT05695690
• The Reproducibility of Microvascular Flow Imaging in Fibroids and Its Correlation With 2D and 3D Power Doppler OutcomesCompletedNCT05643339
• Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.Status unknownNCT05620355Phase 3
• Are Uterine Fibroids Pro-thrombotic?Active, not recruitingNCT05607602
• In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine FibroidsCompletedNCT05604001Not applicable
• The Clinical Trial About Treatment of Benign Uterus Myoma by Haifu Focused Ultrasound Tumor Therapeutic SystemStatus unknownNCT05569200Not applicable
• Evaluating Tibolone Add-back in Patients With Endometriosis and FibroidsWithdrawnNCT05568940

← Leiomyoma overview